OpenVSafe by OpenVAERS
Search V-safe

ZDL-26795-07413

4 vaccinations 22 coded responses 50 check-ins 21 free-text entries 3 call cases
Sex
Male
Age at first dose
46-50
ZIP prefix
582 / ND
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-08
    Registered in v-safe
  3. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Nausea
    Adult check-in
  4. 2021-01-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Headache
    Free text: Mild dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-14
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-21
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Pain in extremity — Feeling: Good
    Free text: Minor pain in joints of toes and hands (rate 2-3 on scale from 1 to 10) that lasted 1-2 days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-28
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-28
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cold sweat, Dizziness, Hyperhidrosis — Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea
    Free text: Dizziness/lightheadedness and sweatiness/cold sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cold sweat — Feeling: Good
    Free text: Cold sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hyperhidrosis, Hypoglycaemia, Paraesthesia oral — Feeling: Poor · Chills · Be unable to work, Be unable to do your normal daily activities
    Free text: Severe sweating, hypoglycemia (blood sugar was 57 and This has never happened before), tingling in tongue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Chills
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Hepatic pain — Feeling: Good · Abdominal pain
    Free text: Dizziness, some pain in area of liver
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-04
    Survey response — day 7, dose 2
    MedDRA: Dizziness — Feeling: Good
    Free text: Dizzy off and on
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-25
    Survey response — day 28, dose 2
    MedDRA: Arthralgia, Pain in extremity, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sinus infectionPain in joints of toes (never experienced this before)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-25
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-29
    Survey response — 6 months, dose 2
    MedDRA: Cough, Ear discomfort, Nasal congestion, Nasal pruritus, Rhinorrhoea — Feeling: Fair
    Free text: Nasal congestion, plugged ears, slight cough, runny/itchy nose with clear discharge
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-09-02
  29. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  30. 2021-10-04
    Survey response — day 0, dose 3
    MedDRA: Dizziness — Feeling: Good · Site: Pain
    Free text: Lightheadedness
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Lightheadedness; unilateral foot pain
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Fatigue or tiredness
    Free text: Lightheadedness
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Light headed
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Hot flush — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Free text: Lightheaded; hot flushes
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness
    Adult check-in
  36. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  37. 2021-10-12
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  38. 2021-10-20
    Survey response — day 14, dose 3
    MedDRA: Sinusitis — Feeling: Fair
    Free text: sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-10-25
    Survey response — day 21, dose 3
    MedDRA: SARS-CoV-2 test, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Vertigo · Healthcare visit (other): Also took covid test at local pharmacy
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-10-25
    Report sent to call center — day 21, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  41. 2021-10-27
  42. 2021-11-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-11-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  44. 2021-11-15
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-01-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-04-04
    Survey response — 6 months, dose 3
    MedDRA: Fatigue, Headache, Myalgia, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Bad head cold with headache (sharp pain), muscle aches, fatigue, sore throat. Three covid tests came back negative.
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-09-16
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  48. 2022-09-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  49. 2022-09-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Gingival discolouration, Gingival erythema, Noninfective gingivitis — Feeling: Fair · Site: Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Red, inflamed gums with white sore on gums.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-09-20
    Survey response — days 1–6 daily, dose 4
    MedDRA: Gingival discolouration, Gingival erythema, Gingival swelling, Noninfective gingivitis — Feeling: Fair · Site: Redness · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Red, puffy, swollen gums with second white sore on gums (my gums are normally pink and healthy)
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-09-21
    Survey response — days 1–6 daily, dose 4
    MedDRA: Gingival erythema, Noninfective gingivitis — Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tiredness
    Free text: Red inflamed gums
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-09-23
    Health check-in — day 7, dose 4
    Feeling: Fair · Site: Redness · Fatigue or tiredness
    Adult check-in
  53. 2022-09-30
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  54. 2022-10-07
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-10-14
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-10-21
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-10-28
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  58. 2022-12-16
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  59. 2023-03-17
    Survey response — 6 months, dose 4
    MedDRA: Malaise, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  60. 2023-03-17
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  61. 2023-03-20
  62. 2023-03-20
  63. 2023-03-23
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  64. 2023-03-23
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  65. 2023-03-23
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Pfizer-BioNTech
22021-01-28Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No
42022-09-16Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2021-02-25 Successful
2023-03-23
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-10-25 Successful
2023-03-23
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-17 Successful
2023-03-23
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-09

Systemic reaction (other): Mild dizziness

Release 2 — day 14, dose 1

2021-01-21

Symptoms: Minor pain in joints of toes and hands (rate 2-3 on scale from 1 to 10) that lasted 1-2 days.

Release 3 — days 1–6 daily, dose 2

2021-01-30

Systemic reaction (other): Dizziness/lightheadedness and sweatiness/cold sweats

2021-01-31

Systemic reaction (other): Cold sweats

2021-02-01

Systemic reaction (other): Severe sweating, hypoglycemia (blood sugar was 57 and This has never happened before), tingling in tongue

2021-02-02

Systemic reaction (other): Dizziness

2021-02-03

Systemic reaction (other): Dizziness, some pain in area of liver

Release 3 — day 7, dose 2

2021-02-04

Systemic reaction (other): Dizzy off and on

Release 4 — day 28, dose 2

2021-02-25

Symptoms: Sinus infectionPain in joints of toes (never experienced this before)

Release 9 — 6 months, dose 2

2021-07-29

Symptoms: Nasal congestion, plugged ears, slight cough, runny/itchy nose with clear discharge

Release 10 — day 0, dose 3

2021-10-04

Systemic reaction (other): Lightheadedness

Release 10 — days 1–6 daily, dose 3

2021-10-05

Systemic reaction (other): Lightheadedness; unilateral foot pain

2021-10-06

Systemic reaction (other): Lightheadedness

2021-10-07

Systemic reaction (other): Light headed

2021-10-08

Systemic reaction (other): Lightheaded; hot flushes

Release 10 — day 14, dose 3

2021-10-20

Symptoms: sinus infection

Release 10 — day 21, dose 3

2021-10-25

Symptoms: Vertigo
Healthcare visit (other): Also took covid test at local pharmacy

Release 11 — 6 months, dose 3

2022-04-04

Symptoms: Bad head cold with headache (sharp pain), muscle aches, fatigue, sore throat. Three covid tests came back negative.

Release 12 — days 1–6 daily, dose 4

2022-09-19

Systemic reaction (other): Red, inflamed gums with white sore on gums.

2022-09-20

Systemic reaction (other): Red, puffy, swollen gums with second white sore on gums (my gums are normally pink and healthy)

2022-09-21

Systemic reaction (other): Red inflamed gums

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSARS-CoV-2 test · · ✓
SDArthralgia ✓ ✓ ✓
SDCough ✓ · ✓
SDEar discomfort ✓ · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDMyalgia · · ✓
SDNasal congestion ✓ · ✓
SDNasal pruritus ✓ · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPain in extremity ✓ ✓ ✓
SDRhinorrhoea ✓ · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinusitis ✓ ✓ ✓
SDVertigo · · ✓
SROCold sweat ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROGingival discolouration · · ✓
SROGingival erythema · · ✓
SROGingival swelling · · ✓
SROHepatic pain ✓ ✓ ✓
SROHot flush · · ✓
SROHyperhidrosis ✓ ✓ ✓
SROHypoglycaemia ✓ ✓ ✓
SRONoninfective gingivitis · · ✓
SROPain in extremity · · ✓
SROParaesthesia oral ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release